o-TOLUIDINE CAS N°: 95-53-4 - UNEP Chemicals

More documents

Recommendations

Info

OECD SIDS o-TOLUIDINE 5. TOXICITY ID: 95-53-4 DATE: 07.01.2005 248 the end of study (no further details reported) - HISTOPATHOLOGY tissues examined: - skin, lungs and bronchi, trachea, bone marrow (femur), - spleen, lymph nodes (mesenteric and submandibular), - thymus, heart, salivary gland (parotid, sublingual, and - subaxillary), liver, pancreas, esophagus, stomach - (glandular and nonglandular), small ang large intestines, - kidney, urinary bladder, pituitary, adrenal, thyroid, - parathyroid, pancreatic islets, testis, prostata, mammary - gland, uterus ovary, brain (cerebrum and cerebellum), and - all tissue masses. Peripheral blood smears were also made - for all animals, whenever possible. STATISTICS: Product-limit procedure of Kaplan and Meier Method of Cox with Tarone's extension Fisher exact test Bonferoni inequality Cochran-Armitage Conclusion : In conclusion, o-toluidine hydrochloride is considered to be carcinogenic in male and female B6C3Fl mice. This is based on the increased incidences of hepatocellular neoplasms in female mice and hemangiosarcomas in high-dose males and of females exposed to the compound. Reliability : (2) valid with restrictions Flag : Critical study for SIDS endpoint 24.05.2004 (159) (360) (356) Species : rat Sex : male Strain : Fischer 344 Route of admin. : oral feed Exposure period : 72 weeks Frequency of treatm. : continuously Post exposure period : approx. 20 weeks Doses : 0, 4000 ppm (mean daily dose per rat - 0.062g, calculated from food consumption) Result : Control group : yes, concurrent no treatment Method : other: carcinogenicity see freetext TC Year : 1982 GLP : no data Test substance : other TS: o-Toluidine hydrochloride, purified by recrystallization: m.p.: 216-218°C Result : ---mean daily food consumption/rat: 15.5 g in the treatment group versus 17.9 g in controls ---mean daily dose: 0.062 g 0-toluidine hydrochloride Mortality: treatment-group: no death up to month 14; month 22: 6/30 surviving rats control-group: no death up to month 12; month 22: 18/30 surviving control rat Mean Body weights: at onset: 132g of dosed rats as well as of controls after 1 year: 454 g(dosed rats) versus 400 g (control rats) after 93 weeks: 474 g (dosed rats) versus 411 g (control rats) Tumor incidences Number of rats necropsied: 30 dosed rats, 27 control rats UNEP PUBLICATIONS
OECD SIDS o-TOLUIDINE 5. TOXICITY ID: 95-53-4 DATE: 07.01.2005 Number of animals with tumors: treatment group versus controls: Liver Hepatoma 2/30 vs 0/27; Adenoma 1/30 vs 1/27 Urinary Bladder Papilloma 3/30 vs 0/27; Carcinoma 1/30 vs 0/30 Skin Fibroma 25/30 vs 1/27 Spleen - Fibroma 10/30 vs 0/30 Mammary tumors Fibroadenoma 11/30 vs 0/27; Adenocarcinoma 2/30 vs 0/27 Peritoneal tumors Mesothelioma 5/30 vs 2/27; Sarcoma 9/30 vs 0/27 Testis - Leydig cell 24/30 vs 24/27 Miscellaneous 12/30 vs 14/27 Test condition : TEST ORGANISMS - Age: 8 weeks at the study start - Weight at study initiation: 132 g - Number of animals: 30 male rats/group ANIMAL MAINTENANCE Housing: 3 rats/cage Diet: NIH-07, ad libitum Water: ad libitum Room air: 21°C, relative humidity: 50 % lightening: light/dark cycle of 12-h duration ADMINISTRATION / EXPOSURE - Administration of TS: 72 weeks - Duration of test: 93 weeks - Post exposure period: approx. 20 weeks - Vehicle: diet (NIH-07) - Concentration in vehicle: 0.028 mol/kg feed = 4g/kg feed = 4000 ppm CLINICAL OBSERVATIONS AND FREQUENCY - Body weight: mean data recorded at the onset, after 1 year and after 73 weeks - Food consumption: in 3 animals/group over a 2 days period every 3 weeks - Clinical signs: no data - Mortality: recorded monthly from month 8 to month 22 of the test period ORGANS EXAMINED AT NECROPSY (MACROSCOPIC AND MICROSCOPIC): - All remaining animals were killed after 93 test weeks. - Upon necropsy, gross lesions and representative samples of major organs (no details specified) were fixed in 10% buffered formalin and processed for microscopic evaluation. STATISTICS: STATISTICAL METHODS: significance was evaluated by the chi-squaretest Reliability : (2) valid with restrictions study doesn't meet the criteria of today: too short in uration, to small number of animals , only one dose, reported in brief Flag : Critical study for SIDS endpoint 03.06.2004 (361) (356) Species : rat Sex : no data Strain : other: no data UNEP PUBLICATIONS 249
Page 1 and 2:
OECD SIDS o-TOLUIDINE FOREWORD INTR
Page 3 and 4:
OECD SIDS o-TOLUIDINE 11. Comments:
Page 5 and 6:
OECD SIDS o-TOLUIDINE and transitio
Page 7 and 8:
OECD SIDS o-TOLUIDINE countries), e
Page 9 and 10:
OECD SIDS o-TOLUIDINE 1.3 Physico-C
Page 11 and 12:
OECD SIDS o-TOLUIDINE methylene-bis
Page 13 and 14:
OECD SIDS o-TOLUIDINE Table 3 Photo
Page 15 and 16:
OECD SIDS o-TOLUIDINE With adapted
Page 17 and 18:
OECD SIDS o-TOLUIDINE Table 8 Geoac
Page 19 and 20:
OECD SIDS o-TOLUIDINE polluted site
Page 21 and 22:
OECD SIDS o-TOLUIDINE depending on
Page 23 and 24:
OECD SIDS o-TOLUIDINE prepared from
Page 25 and 26:
OECD SIDS o-TOLUIDINE 3.1.2 Acute T
Page 27 and 28:
OECD SIDS o-TOLUIDINE 3.1.4 Sensiti
Page 29 and 30:
OECD SIDS o-TOLUIDINE Inhalation Th
Page 31 and 32:
OECD SIDS o-TOLUIDINE males or fema
Page 33 and 34:
OECD SIDS o-TOLUIDINE examination y
Page 35 and 36:
OECD SIDS o-TOLUIDINE Conclusion Th
Page 37 and 38:
OECD SIDS o-TOLUIDINE According to
Page 39 and 40:
OECD SIDS o-TOLUIDINE The lowest te
Page 41 and 42:
OECD SIDS o-TOLUIDINE 4.2 Terrestri
Page 43 and 44:
OECD SIDS o-TOLUIDINE 6 REFERENCES
Page 45 and 46:
OECD SIDS o-TOLUIDINE Bringmann G,
Page 47 and 48:
OECD SIDS o-TOLUIDINE Hecht SS, El-
Page 49 and 50:
OECD SIDS o-TOLUIDINE phase extract
Page 51 and 52:
OECD SIDS o-TOLUIDINE Stark M (1892
Page 53 and 54:
OECD SIDS o-TOLUIDINE I U C L I D D
Page 55 and 56:
OECD SIDS o-TOLUIDINE 1. GENERAL IN
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
OECD SIDS o-TOLUIDINE 2. PHYSICO-CH
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
OECD SIDS o-TOLUIDINE 3. ENVIRONMEN
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
OECD SIDS o-TOLUIDINE 4. ECOTOXICIT
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
OECD SIDS o-TOLUIDINE 5. TOXICITY I
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198: OECD SIDS o-TOLUIDINE 5. TOXICITY I
Page 247: OECD SIDS o-TOLUIDINE 5. TOXICITY I
Page 275 and 276: OECD SIDS o-TOLUIDINE 6. REFERENCES
Page 297: OECD SIDS o-TOLUIDINE 6. REFERENCES
show all

o-TOLUIDINE CAS N°: 95-53-4 - UNEP Chemicals

Create successful ePaper yourself

Delete template?

Save as template?